Taste Properties of HIV Inhibitor

• Status: Completed
• Trial end date: 2016-05-24
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of the study is to assess the taste properties of HIV inhibitor

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Bristol-Myers Squibb; ViiV Healthcare
• Collaborator: Senopsys, LLC
• Treatments: BMS-955176

Criteria

For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com

Inclusion Criteria:

• Men and women of non-childbearing potential professional sensory panelists

• Aged between 25 and 80 years

Exclusion Criteria:

• History of relevant drug or food allergies, cardiovascular or Central nervous system (CNS) disease, clinically significant pathology, history of mental illness

• Positive HIV test